If the management would hint which biotech field the new technology refers too (cancer, skin diseases, sex erection, menopause, headache, bloating, shareholders irritable syndrome, etc...), maybe we could all understand more if it is again another bullshit story to raise money or if there is still some juice to get out from us or new potential ready to be diluted shareholders.
This management (some of them sitting on the Board from day 1) has failed very bad for a previous technology held 11 years in the portfolio, so we need more to assess if they are making again the same prophetical mistake of another "miracle" protein.
We are not so idiot or retardet to not understand if we have true potential. Are we speaking about a blockbuster technology or about a niche patient market? Is it something to be tested and approved before in Australia, before risking fortunes abroad? What the hell is again in the mind of this well known management team?
You have to understand that we praise only success and not stupidity.
FTT Price at posting:
0.3¢ Sentiment: None Disclosure: Held
